An International Multicenter Study Of Intravenous Bevacizumab For The Treatment Of Chronic Bleeding And Anemia In Hereditary Hemorrhagic Telangiectasia: The Inhibit-Bleed Study

BLOOD(2019)

引用 0|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要